159 related articles for article (PubMed ID: 24015326)
1. Adenosine Dioxolane Nucleoside Phosphoramidates as Antiviral Agents for Human Immunodeficiency and Hepatitis B Viruses.
Bondada L; Detorio M; Bassit L; Tao S; Montero CM; Singletary TM; Zhang H; Zhou L; Cho JH; Coats SJ; Schinazi RF
ACS Med Chem Lett; 2013 Aug; 4(8):747-751. PubMed ID: 24015326
[TBL] [Abstract][Full Text] [Related]
2. Phosphoramidate prodrugs of (-)-β-D-(2R,4R)-dioxolane-thymine (DOT) as potent anti-HIV agents.
Wang P; Rachakonda S; Zennou V; Keilman M; Niu C; Bao D; Ross BS; Furman PA; Otto MJ; Sofia MJ
Antivir Chem Chemother; 2012 May; 22(5):217-38. PubMed ID: 22358223
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antiviral evaluation of 2-amino-6-carbamoylpurine dioxolane nucleoside derivatives and their phosphoramidates prodrugs.
Cho JH; Bondana L; Detorio MA; Montero C; Bassit LC; Amblard F; Coats SJ; Schinazi RF
Bioorg Med Chem; 2014 Dec; 22(23):6665-6671. PubMed ID: 25458500
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of novel distamycin-modified nucleoside analogues as HIV-1 reverse transcriptase inhibitors.
Li C; Ma C; Zhang J; Qian N; Ding J; Qiao R; Zhao Y
Antiviral Res; 2014 Feb; 102():54-60. PubMed ID: 24342709
[TBL] [Abstract][Full Text] [Related]
5. Dioxolane guanosine, the active form of the prodrug diaminopurine dioxolane, is a potent inhibitor of drug-resistant HIV-1 isolates from patients for whom standard nucleoside therapy fails.
Mewshaw JP; Myrick FT; Wakefield DA; Hooper BJ; Harris JL; McCreedy B; Borroto-Esoda K
J Acquir Immune Defic Syndr; 2002 Jan; 29(1):11-20. PubMed ID: 11782585
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of action of 1-beta-D-2,6-diaminopurine dioxolane, a prodrug of the human immunodeficiency virus type 1 inhibitor 1-beta-D-dioxolane guanosine.
Furman PA; Jeffrey J; Kiefer LL; Feng JY; Anderson KS; Borroto-Esoda K; Hill E; Copeland WC; Chu CK; Sommadossi JP; Liberman I; Schinazi RF; Painter GR
Antimicrob Agents Chemother; 2001 Jan; 45(1):158-65. PubMed ID: 11120959
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of phosphoramidate prodrugs: ProTide approach.
Serpi M; Madela K; Pertusati F; Slusarczyk M
Curr Protoc Nucleic Acid Chem; 2013 Jun; Chapter 15():15.5.1-15.5.15. PubMed ID: 23775807
[TBL] [Abstract][Full Text] [Related]
8. Application of phosphoramidate pronucleotide technology to abacavir leads to a significant enhancement of antiviral potency.
McGuigan C; Harris SA; Daluge SM; Gudmundsson KS; McLean EW; Burnette TC; Marr H; Hazen R; Condreay LD; Johnson L; De Clercq E; Balzarini J
J Med Chem; 2005 May; 48(10):3504-15. PubMed ID: 15887959
[TBL] [Abstract][Full Text] [Related]
9. Application of the phosphoramidate ProTide approach to 4'-azidouridine confers sub-micromolar potency versus hepatitis C virus on an inactive nucleoside.
Perrone P; Luoni GM; Kelleher MR; Daverio F; Angell A; Mulready S; Congiatu C; Rajyaguru S; Martin JA; Levêque V; Le Pogam S; Najera I; Klumpp K; Smith DB; McGuigan C
J Med Chem; 2007 Apr; 50(8):1840-9. PubMed ID: 17367121
[TBL] [Abstract][Full Text] [Related]
10. First example of phosphoramidate approach applied to a 4'-substituted purine nucleoside (4'-azidoadenosine): conversion of an inactive nucleoside to a submicromolar compound versus hepatitis C virus.
Perrone P; Daverio F; Valente R; Rajyaguru S; Martin JA; Lévêque V; Le Pogam S; Najera I; Klumpp K; Smith DB; McGuigan C
J Med Chem; 2007 Nov; 50(22):5463-70. PubMed ID: 17914786
[TBL] [Abstract][Full Text] [Related]
11. Application of phosphoramidate ProTide technology significantly improves antiviral potency of carbocyclic adenosine derivatives.
McGuigan C; Hassan-Abdallah A; Srinivasan S; Wang Y; Siddiqui A; Daluge SM; Gudmundsson KS; Zhou H; McLean EW; Peckham JP; Burnette TC; Marr H; Hazen R; Condreay LD; Johnson L; Balzarini J
J Med Chem; 2006 Nov; 49(24):7215-26. PubMed ID: 17125274
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anti-HIV activity of (-)-beta-D-(2R,4R)-1,3-dioxolane-2,6-diamino purine (DAPD) (amdoxovir) and (-)-beta-D-(2R,4R)-1,3-dioxolane guanosine (DXG) prodrugs.
Narayanasamy J; Pullagurla MR; Sharon A; Wang J; Schinazi RF; Chu CK
Antiviral Res; 2007 Sep; 75(3):198-209. PubMed ID: 17532483
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 resistance profile of the novel nucleoside reverse transcriptase inhibitor beta-D-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine (Reverset).
Geleziunas R; Gallagher K; Zhang H; Bacheler L; Garber S; Wu JT; Shi G; Otto MJ; Schinazi RF; Erickson-Viitanen S
Antivir Chem Chemother; 2003 Jan; 14(1):49-59. PubMed ID: 12790516
[TBL] [Abstract][Full Text] [Related]
14. Phosphoramidate pronucleotides: a comparison of the phosphoramidase substrate specificity of human and Escherichia coli histidine triad nucleotide binding proteins.
Chou TF; Baraniak J; Kaczmarek R; Zhou X; Cheng J; Ghosh B; Wagner CR
Mol Pharm; 2007; 4(2):208-17. PubMed ID: 17217311
[TBL] [Abstract][Full Text] [Related]
15. N4-acyl-modified D-2',3'-dideoxy-5-fluorocytidine nucleoside analogues with improved antiviral activity.
Shi J; Mathew JS; Tharnish PM; Rachakonda S; Pai SB; Adams M; Grier JP; Gallagher K; Zhang H; Wu JT; Shi G; Geleziunas R; Erickson-Viitanen S; Stuyver L; Otto MJ; Watanabe KA; Schinazi RF
Antivir Chem Chemother; 2003 Mar; 14(2):81-90. PubMed ID: 12856919
[TBL] [Abstract][Full Text] [Related]
16. Aryloxy phosphoramidate triesters: a technology for delivering monophosphorylated nucleosides and sugars into cells.
Mehellou Y; Balzarini J; McGuigan C
ChemMedChem; 2009 Nov; 4(11):1779-91. PubMed ID: 19760699
[TBL] [Abstract][Full Text] [Related]
17. Anti-HIV efficacy and biodistribution of nucleoside reverse transcriptase inhibitors delivered as squalenoylated prodrug nanoassemblies.
Hillaireau H; Dereuddre-Bosquet N; Skanji R; Bekkara-Aounallah F; Caron J; Lepêtre S; Argote S; Bauduin L; Yousfi R; Rogez-Kreuz C; Desmaële D; Rousseau B; Gref R; Andrieux K; Clayette P; Couvreur P
Biomaterials; 2013 Jul; 34(20):4831-8. PubMed ID: 23562054
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of novel (2R,4R)- and (2S,4S)-iso dideoxynucleosides with exocyclic methylene as potential antiviral agents.
Yoo SJ; Kim HO; Lim Y; Kim J; Jeong LS
Bioorg Med Chem; 2002 Jan; 10(1):215-26. PubMed ID: 11738624
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anti-herpetic activity of phosphoramidate ProTides.
Maiti M; Persoons L; Andrei G; Snoeck R; Balzarini J; Herdewijn P
ChemMedChem; 2013 Jun; 8(6):985-93. PubMed ID: 23606629
[TBL] [Abstract][Full Text] [Related]
20. An introduction to nucleoside and nucleotide analogues.
Squires KE
Antivir Ther; 2001; 6 Suppl 3():1-14. PubMed ID: 11678469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
